Air Pollution is Linked to Adverse Brain Development in Young Children 26/09/2022 Stefan Anderson Infants’ brains are negatively affected by air pollution, according to a study which has documented the effects of children’s exposure to air pollution from conception to the age of eight-and-a-half years for the first time. Tracking 3,515 children aged 9-12, the study found an association between exposure to air pollutants in the womb and their […] Continue reading -> WHO Unveils ‘Invisible Numbers’ of the NCD Crisis as Leaders Meet at United Nations 21/09/2022 Stefan Anderson Around two-thirds of Africans with non-communicable diseases (NCDs) die prematurely – before the age of 70. In Europe, less than a third of people living with NCDs die that early. This is just one of the stark statistics contained in the most extensive data-visualization tool yet produced by the World Health Organization (WHO) to assist […] Continue reading -> World Patient Safety Day: Ensuring Medicines are Properly Prescribed 16/09/2022 Stefan Anderson “We all know that medicines save lives, but they can also harm in cases where they are inappropriately prescribed, taken the wrong way, without proper monitoring, or are not of an adequate quality,” said World Health Organization (WHO) Deputy Director-General Dr Zsuzsanna Jakab as she opened the floor on World Patient Safety Day 2022. The […] Continue reading -> Call for Fossil Fuel ‘Nonproliferation’ Treaty Sets High Stakes for Climate Talks 14/09/2022 Stefan Anderson Nearly 200 health organizations and more than 1,400 health professionals have signed a letter published on Wednesday calling on governments to negotiate a legally binding international treaty that would phase out fossil fuels, which they blame for “severe threats to human and planetary health.” Among the treaty’s supporters is the World Health Organization (WHO), a […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Breaking: DNDi Founder Bernard Pécoul Steps Down After 19 Years 05/09/2022 Stefan Anderson The Drugs for Neglected Diseases initiative (DNDi), one of the most important nonprofit drug developers in the world, has appointed a new leader to fill the shoes of its outgoing founder. Dr Luis Pizarro, a Chilean-French doctor and global health expert, will serve as DNDi’s new executive director, succeeding DNDi founder Dr Bernard Pécoul, who […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Unveils ‘Invisible Numbers’ of the NCD Crisis as Leaders Meet at United Nations 21/09/2022 Stefan Anderson Around two-thirds of Africans with non-communicable diseases (NCDs) die prematurely – before the age of 70. In Europe, less than a third of people living with NCDs die that early. This is just one of the stark statistics contained in the most extensive data-visualization tool yet produced by the World Health Organization (WHO) to assist […] Continue reading -> World Patient Safety Day: Ensuring Medicines are Properly Prescribed 16/09/2022 Stefan Anderson “We all know that medicines save lives, but they can also harm in cases where they are inappropriately prescribed, taken the wrong way, without proper monitoring, or are not of an adequate quality,” said World Health Organization (WHO) Deputy Director-General Dr Zsuzsanna Jakab as she opened the floor on World Patient Safety Day 2022. The […] Continue reading -> Call for Fossil Fuel ‘Nonproliferation’ Treaty Sets High Stakes for Climate Talks 14/09/2022 Stefan Anderson Nearly 200 health organizations and more than 1,400 health professionals have signed a letter published on Wednesday calling on governments to negotiate a legally binding international treaty that would phase out fossil fuels, which they blame for “severe threats to human and planetary health.” Among the treaty’s supporters is the World Health Organization (WHO), a […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Breaking: DNDi Founder Bernard Pécoul Steps Down After 19 Years 05/09/2022 Stefan Anderson The Drugs for Neglected Diseases initiative (DNDi), one of the most important nonprofit drug developers in the world, has appointed a new leader to fill the shoes of its outgoing founder. Dr Luis Pizarro, a Chilean-French doctor and global health expert, will serve as DNDi’s new executive director, succeeding DNDi founder Dr Bernard Pécoul, who […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Patient Safety Day: Ensuring Medicines are Properly Prescribed 16/09/2022 Stefan Anderson “We all know that medicines save lives, but they can also harm in cases where they are inappropriately prescribed, taken the wrong way, without proper monitoring, or are not of an adequate quality,” said World Health Organization (WHO) Deputy Director-General Dr Zsuzsanna Jakab as she opened the floor on World Patient Safety Day 2022. The […] Continue reading -> Call for Fossil Fuel ‘Nonproliferation’ Treaty Sets High Stakes for Climate Talks 14/09/2022 Stefan Anderson Nearly 200 health organizations and more than 1,400 health professionals have signed a letter published on Wednesday calling on governments to negotiate a legally binding international treaty that would phase out fossil fuels, which they blame for “severe threats to human and planetary health.” Among the treaty’s supporters is the World Health Organization (WHO), a […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Breaking: DNDi Founder Bernard Pécoul Steps Down After 19 Years 05/09/2022 Stefan Anderson The Drugs for Neglected Diseases initiative (DNDi), one of the most important nonprofit drug developers in the world, has appointed a new leader to fill the shoes of its outgoing founder. Dr Luis Pizarro, a Chilean-French doctor and global health expert, will serve as DNDi’s new executive director, succeeding DNDi founder Dr Bernard Pécoul, who […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Call for Fossil Fuel ‘Nonproliferation’ Treaty Sets High Stakes for Climate Talks 14/09/2022 Stefan Anderson Nearly 200 health organizations and more than 1,400 health professionals have signed a letter published on Wednesday calling on governments to negotiate a legally binding international treaty that would phase out fossil fuels, which they blame for “severe threats to human and planetary health.” Among the treaty’s supporters is the World Health Organization (WHO), a […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Breaking: DNDi Founder Bernard Pécoul Steps Down After 19 Years 05/09/2022 Stefan Anderson The Drugs for Neglected Diseases initiative (DNDi), one of the most important nonprofit drug developers in the world, has appointed a new leader to fill the shoes of its outgoing founder. Dr Luis Pizarro, a Chilean-French doctor and global health expert, will serve as DNDi’s new executive director, succeeding DNDi founder Dr Bernard Pécoul, who […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Breaking: DNDi Founder Bernard Pécoul Steps Down After 19 Years 05/09/2022 Stefan Anderson The Drugs for Neglected Diseases initiative (DNDi), one of the most important nonprofit drug developers in the world, has appointed a new leader to fill the shoes of its outgoing founder. Dr Luis Pizarro, a Chilean-French doctor and global health expert, will serve as DNDi’s new executive director, succeeding DNDi founder Dr Bernard Pécoul, who […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Breaking: DNDi Founder Bernard Pécoul Steps Down After 19 Years 05/09/2022 Stefan Anderson The Drugs for Neglected Diseases initiative (DNDi), one of the most important nonprofit drug developers in the world, has appointed a new leader to fill the shoes of its outgoing founder. Dr Luis Pizarro, a Chilean-French doctor and global health expert, will serve as DNDi’s new executive director, succeeding DNDi founder Dr Bernard Pécoul, who […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Newer posts